DANIEL W JUNICK M.D.
Prescription History 1891773339
Orthopaedic Surgery in Albuquerque, NM


Quality Rating: 75 out of 100 score

NPI Status: Active since January 05, 2006

Contact Information

201 CEDAR ST SE
SUITE 6600
ALBUQUERQUE, NM
ZIP 87106
Phone: (505) 724-4300
Fax: (505) 724-4384

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DANIEL W JUNICK M.D., an active Orthopaedic Surgery specialist practicing in Albuquerque, NM. Our medical registry currently tracks 11 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 555 documented patient claims. Among these therapy options, the most frequently utilized medication is Meloxicam, which accounts for 156 claims alone.


Amoxicillin

Generic Formulation: AmoxicillinSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 88
30-Day Fills 88.0
Days Supply 206
NM State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills40.7
Peer Average Days Supply294
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 120.0% higher than the standard regional baseline profile for NM. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $128.98 across this reporting matrix range.

Provider Avg Cost Per Claim

$1.47

State Avg Cost Per Claim

$4.17

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.

Therapeutic Applications

Amoxicillin is used to treat a wide variety of bacterial infections. This medication is a penicillin-type antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Amoxicillin is also used with other medications to treat stomach/intestinal ulcers caused by the bacteria H. pylori and to prevent the ulcers from returning.

Celecoxib

Generic Formulation: CelecoxibSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 43
30-Day Fills 53.0
Days Supply 1,590
NM State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills51.6
Peer Average Days Supply1,525
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 43.3% more claims than the standard regional baseline profile for NM. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,250.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$29.09

State Avg Cost Per Claim

$55.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.

Therapeutic Applications

This medication is a nonsteroidal anti-inflammatory drug (NSAID), specifically a COX-2 inhibitor, which relieves pain and swelling (inflammation). It is used to treat arthritis, acute pain, and menstrual pain and discomfort. The pain and swelling relief provided by this medication helps you perform more of your normal daily activities. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. This drug works by blocking the enzyme in your body that makes prostaglandins. Decreasing prostaglandins helps to reduce pain and swelling.

Clindamycin Hcl

Generic Formulation: Clindamycin HclSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 18
30-Day Fills 18.0
Days Supply 27
NM State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills20.4
Peer Average Days Supply157
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NM. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $40.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.27

State Avg Cost Per Claim

$10.76

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.

Therapeutic Applications

Clindamycin is used to treat a wide variety of bacterial infections. It is an antibiotic that works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Doxycycline Hyclate

Generic Formulation: Doxycycline HyclateSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 330
NM State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills27.0
Peer Average Days Supply404
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 54.2% less volume than the regional standard for practitioners inside NM. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $112.27 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.21

State Avg Cost Per Claim

$24.61

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic tetracycline derivative with similar antimicrobial activity.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 53
30-Day Fills 53.0
Days Supply 940
NM State Average Benchmarks
Peer Average Claims64.0
Peer Average 30-Day Fills64.2
Peer Average Days Supply1,402
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NM. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $314.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.93

State Avg Cost Per Claim

$19.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Meloxicam

Generic Formulation: MeloxicamSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 156
30-Day Fills 196.0
Days Supply 5,767
NM State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills68.1
Peer Average Days Supply2,014
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 290.0% higher than the standard regional baseline profile for NM. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $817.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.24

State Avg Cost Per Claim

$8.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

Therapeutic Applications

Meloxicam is used to help relieve moderate to severe pain. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling or pain.

Methocarbamol

Generic Formulation: MethocarbamolSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 50
30-Day Fills 50.0
Days Supply 445
NM State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills26.3
Peer Average Days Supply603
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 117.4% higher than the standard regional baseline profile for NM. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $181.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$3.62

State Avg Cost Per Claim

$13.26

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1206)

Therapeutic Applications

Methocarbamol is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

Mupirocin

Generic Formulation: MupirocinSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 24
30-Day Fills 24.0
Days Supply 318
NM State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills28.0
Peer Average Days Supply441
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NM. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $142.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.95

State Avg Cost Per Claim

$11.60

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.

Therapeutic Applications

Mupirocin is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria.

Oxycodone Hcl

Generic Formulation: Oxycodone HclSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 67
30-Day Fills 67.0
Days Supply 564
NM State Average Benchmarks
Peer Average Claims56.0
Peer Average 30-Day Fills56.3
Peer Average Days Supply1,299
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NM. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $383.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.72

State Avg Cost Per Claim

$22.55

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic derivative of CODEINE.

Therapeutic Applications

This medication is used to help relieve moderate to severe pain. Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Tramadol Hcl

Generic Formulation: Tramadol HclSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 32
30-Day Fills 32.0
Days Supply 327
NM State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills46.1
Peer Average Days Supply978
Conservative Utilization

This provider writes prescriptions for this formulation 28.9% less frequently than the standard regional baseline metric for practitioners inside NM. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $73.53 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.30

State Avg Cost Per Claim

$7.96

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A narcotic analgesic proposed for severe pain. It may be habituating.

Therapeutic Applications

See also Warning section. This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Xarelto

Generic Formulation: RivaroxabanSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 222
NM State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills75.0
Peer Average Days Supply2,176
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 69.0% less volume than the regional standard for practitioners inside NM. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,169.86 across this reporting matrix range.

Provider Avg Cost Per Claim

$320.76

State Avg Cost Per Claim

$901.52

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.

Therapeutic Applications

Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DANIEL W JUNICK M.D. provides transparency into local medical care patterns within Albuquerque, NM.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Orthopaedic Surgery** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.